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Background/aim: Healthy life style recommendations (e.g., physical activity, healthy diet, and decreased cholesterol levels) play an
important role in controlling blood pressure (BP). This study aimed to assess lifestyle modification factors among patients diagnosed
with hypertension.
Materials and methods: A descriptive-survey design was used. Data were collected using four questionnaires; one was the Beliefs about
Medication questionnaire (BMQ) and the rest were developed to collect data about demographic and clinical characteristics and lifestyle
modification factors.
Results: In total 312 questionnaires were completed. The results revealed that our participants did not follow the healthy lifestyle
recommendations; for example, the mean blood sugar (BS) level, body mass index (BMI), and cholesterol levels were 155 mg/dL
(standard deviation (SD) = 71.9), 29 kg/m2 (SD = 5.4), and 197 mg/dL (SD = 86.6), respectively. A significant correlation was shown
between age and BP (P = 0.000). Increase in diastolic BP (DBP) correlated with a significant increase in cholesterol level (P = 0.002) and
BMI (P = 0.006).
Conclusion: Our study showed that somewhat hypertensive patients in Jordan did not follow a healthy lifestyle. Therefore, urgent action
by addressing behavioral risk factors has a positive impact on preventing and controlling hypertension.
Key words: Hypertension, adherence, cholesterol, blood sugar, body mass index, healthy lifestyle modification factors

1. Introduction
The prevalence of hypertension is increasing, mainly in
developing countries, as a result of exposure to its risk
factors (e.g., obesity, stress) (1). In 2008 approximately 40%
of adults worldwide were diagnosed with hypertension
(1); it is one of the most prevalent conditions in Jordan,
with in excess of 26% of people suffering from it (2–5).
Hypertension contributes to the burden of different health
conditions, such as heart disease, stroke, and kidney
failure (1). Additionally it leads to increased mortality
and disability, mainly in low and middle income countries
(3,6,7). Around 9.4 million deaths worldwide result from
hypertension every year (3). To counter this situation
long-term care is needed, which requires increased health
expenditure (8). The health expenditure associated with
noncommunicable diseases (e.g., hypertension, diabetes,
and cancer), over the period 2011–2025 in low and middle
income countries is estimated to be US$ 7.28 trillion.
Around half of that cost results from cardiovascular
* Correspondence: fhalaiqa@philadelphia.edu.jo

diseases including myocardial infarction and angina
pectoris, which are associated with hypertension (8,9).
Controlling blood pressure (BP) is the major goal that
could be achieved by adherence to antihypertensive drugs
and lifestyle modification recommendations (7). Early
detection, treatment, and good control of hypertension are
associated with significant positive effects on both health
and economic aspects (3).
Suitable drug therapy reduces the risk of morbidity
and mortality among patients who complain of increased
BP. However, BP is not properly controlled among
hypertensive patients in Jordan, with around 70% of
such patients failing to achieve their BP controlling
goals (10,11). Behavioral risk factors play an important
role in developing hypertension, for example, a salt- and
fat-rich diet, alcohol use, physical inactivity, poor stress
management, obesity, having diabetes mellitus, high
cholesterol, and smoking (3). The prevalence of these
risk factors in Jordan is high (3,12–14). Unfortunately,
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most of Jordan’s hypertensive patients are not following
their lifestyle modification recommendations (3,11,15),
which are strongly recommended before any initiation
of drug therapy. Such advice should always be followed
by hypertensive patients requiring single or combined
antihypertensive therapy (16).
The rate of adherence to medication among
hypertensive patients is between 30% and 88% (2, 17).
However, the nonadherence rate to lifestyle modification
recommendations is higher (15). Evidence suggests that
adherence to nonpharmacological interventions (e.g., low
sodium diet and appropriate exercise) has a great impact
on the reduction of BP (3,18–20). Therefore, this study was
carried out to answer the following research questions:
1- What are the lifestyle modification factors that are
followed and adhered to by hypertensive patients?
2- Are there correlations between blood pressure (BP) and
selected modifying factors (i.e. age, cholesterol level,
blood sugar (BS) level, body mass index (BMI), Beliefs
about Medication questionnaire (BMQ) subscales)?
The aim of this study was to assess lifestyle
recommendations among Jordanian patients having high
BP.
2. Materials and methods
2.1. Design
A descriptive design was used because it is suitable when
we intend to collect data over a short period at defined
times.
2.2. Participants and setting
A convenience sampling technique was used to include
participants from outpatient clinics in four government
hospitals that cover most of the geographical area of
Jordan. Participants were included in this study if they met
the following criteria: hypertensive patient aged 18 years
or above, was taking regular medication to control their
BP, had no clear cognitive abnormality, was able to read
and write Arabic, and had follow-up appointments at an
outpatient clinic. Patients who had end-stage renal failure,
movement disability, bone and joint diseases, multiple
sclerosis, and/or myasthenia gravis were all excluded to
reduce the effect of confounding factors.
2.3. Ethical considerations
Ethical approval was obtained from Jordan’s Ministry of
Health and the four hospitals from which the participants
were recruited. Each participant signed an informed
consent before taking part. The participants’ rights (e.g.,
freely participating, could withdraw at any time) were
explained and confidentiality was confirmed. The data
were stored on computer by the primary author. The data
can be accessed by the primary author using a password.
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2.4. Recruitment procedure
To reduce the risk of assessment bias, research assistants
(RAs) (three nurses who have bachelor degrees in nursing)
were trained before data collection about the procedure
and how to handle the questionnaires. Additionally,
during data collection they contacted the main researcher
when they faced any challenges. Each patient’s health
record was reviewed by the RAs. All participants who met
the inclusion criteria were handed the information sheet.
Those who showed interest in the study were interviewed by
the RAs to answer the patient’s questions about the study;
then they signed the informed consent and completed the
questionnaires (filling out the questionnaires required an
average of 15 min).
2.5. Data collection methods
The data were collected using a self-reported specifically
developed questionnaire and a general BMQ 12 (21). It
contains four parts with 17 items in total to assess beliefs
toward medication. Each item is rated from “0” (indicating
strongly disagree) to “5” (indicating strongly agree). The
four parts of BMQ 12 measure the following positive and
negative beliefs:
1- General harm (GH): four questions that measure
beliefs toward the harmfulness of medication.
2- General overuse (GO): four questions that measure
beliefs toward the way of prescribing/overprescribing
of drugs by physician.
3- General sensitivity (GS): five questions that measure
beliefs toward medication’s adverse events and
sensitivity.
4- General benefit (GB): four questions that measure
positive beliefs toward drugs (i.e. benefits).
We used a valid and reliable Arabic version of the
Beliefs about Medication questionnaire (BMQ 12) (with
Cronbach alpha coefficient 0.71) (5). BMQ 12 was used
to assess the patients’ beliefs and correlate them with
their levels of adherence to their lifestyle modification
recommendations. Meanwhile, the specifically developed
questionnaire included:
1- Demographic characteristics (e.g., age, sex, insurance
status, occupation, marital status, education, and
income).
2- Clinical characteristics: BP, cholesterol level, BS, comorbidity, disease duration, height, weight, and BMI.
3- Adherence to lifestyle factors and drugs: obesity,
BP (frequency of checking, having a BP machine),
BS monitoring, smoking, exercise (frequency, type,
barriers), diet, compliance to medication regimen,
having stress and methods used to deal with it.
2.6. Sample size
A power equation was used to determine that the sample
size for this research needed to be 211 patients, based on
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confidence interval of 1.96, 16.5% prevalence of adherence
to modification factors among hypertensive patients, and a
margin of error of 5%. Taking into consideration the dropout rate, the optimal sample size was calculated to be 300
patients.
2.7. Data analysis
To describe the characteristics of the participants’
descriptive statistics were used: frequency and percentage
were used for qualitative variables; mean and standard
deviation were used for quantitative variables. The
correlations between BP and selected modifying factors
were examined by bivariate correlations.

3. Results
3.1. Demographical characteristics
A total of 350 questionnaires were distributed during
the study period; the returned questionnaires totaled
312, which had been completed by patients over 5
months (August–December 2013). The participants had
a mean age of 57.6 years (SD = 11.8) for all age groups
and mean income 295.4 Jordanian Dinars (=$413) (SD
= 201.8). Fifty-six percent of the participants were male,
92% had Jordanian nationality, 83% were educated, 88%
were married, 96% lived with their family, 52% were not
working, and 79.5% had medical insurance (see Table 1).

Table 1. Demographical characteristics of the participants (n = 312) (Jordan, 2013).
Frequency

Percent

≤34

5

1.6

35–44

30

9.6

45–54

100

32.1

55–64

85

27.2

≥65

92

29.5

0–200 JD

27

8.7

201–400

216

69.2

401–600

46

14.7

>600

23

7.4

Age (in years)

Income (Jordanian Dinar)

Sex
Nationality
Education

Marital status

Living status

Insured

Working

Mean

SD

57.6

11.8

395.4

201.8

Frequency

Percent

Male

176

56.4

Female

136

43.6

Jordanian

286

92.0

Other

26

8.0

Educated

259

83.0

Not educated

53

17.0

Married

276

88.4

Single

8

2.6

Widowed

21

8.0

Divorced

7

1.0

Alone
Family (husband /wife/children/
mother/father)
Others

12

3.8

299

95.9

1

.3

Yes

248

79.5

No

64

20.5

Yes

64

20.5

No

163

52.3

Retired

85

27.2

n: total number of participants
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3.2. Clinical characteristics
Tables 2 and 3 show the clinical characteristics of the
participants; more than half of the participants (52%)
had two types of disease or more (co-morbid who had
hypertension and another disease) while less than half of
the patients only had hypertension as a disease without comorbidity (48%). The mean duration of being ill (whether
for patients who only had hypertension and those who
were co-morbid) for all participants was around 1 year
(0.9) (standard deviation (SD) = 0.8). The mean cholesterol
level was around 197 mg/dL; 33% of participants had a
level around 150–200 mg/dL and around 19% of them
had a cholesterol level above 200 mg/dL. The mean of
BMI was 29 kg/m2 (SD = 5.4) with 68.6% of patients being
overweight (37% of the overweight were classified as preobese).

The means of SBP and DBP were 145.7 mmHg (SD =
17) and 95.7 (SD = 10.9) mmHg, respectively. The mean
BS level was 155 mg/dL (SD = 71.9). The data revealed that
participants believed their medication was intrinsically
harmful (mean (M) = 14; SD = 2.9); was overused by
doctors (M = 15; SD = 3.3); patients were very sensitive
to its adverse effects (M = 17; SD = 4.6), but they also
believed that there were positive characteristics regarding
their medication (M = 15.3; SD = 2.6) (see Tables 2 and 3).
3.3. Patients’ health-related behaviors
Regarding health-related behaviors, more than half
(59.6%) of the participants showed adherence to a low
sodium diet, 54.5% never smoked, and 53.5% had a BP
monitoring machine at home, but 52.2% did not measure
their BP (52.2%) and 64.4% did not measure their BS
levels.

Table 2. Clinical characteristics (categorical variables) of the participants (n = 312) (Jordan, 2013).

Co-morbidity

Cholesterol

Frequency

Percent

No

149

47.8

Two types or more

163

52.2

Less than 150 mg/dL

51

16.3

150–200 mg/dL

102

33

Above 200 mg/dL

60

19.2

Table 3. Clinical characteristics (continuous variables) of the participants (n = 312) (Jordan, 2013).
Minimum

Maximum

Mean

Std. deviation

Disease duration in years

0

2

0.9

0.8

Height (centimeters)

140.0

197.0

169.4

8.7

Weight (kilograms)

45.0

170.0

83.2

14.8

BMI (kilograms/m )

18.6

51

29

5.4

Cholesterol (mg/dL)

63.0

600.0

197.3

86.6

SBP (mmHg)

106.0

195.0

145.7

17.2

DBP (mmHg)

60.0

150.0

94.7

10.9

BS (mg/dL)

69

440

155

71.9

Frequency of exercise per week

0.0

2.0

0.4

0.6

Frequency of medication per day

0.0

4.0

1.6

0.7

GH

7

20

14

2.9

GO

8

45

15

3.3

GB

8

20

15.3

2.6

GS

7

54

17

4.6

2

SBP: systolic blood pressure
BMI: body mass index
GO: general overuse
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DBP: diastolic blood pressure
BMQ: beliefs about medication questionnaire
GB: general benefit

BS: blood sugar
GH: general harm
GS: general sensitivity
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Doing exercise was reported by 41.7% of the
participants, with 86.9% of them doing some walking
exercise. Meanwhile, 58.3% did not do any exercise
because they reported some barriers, with around half of
those (45%) reporting “feelings of tiredness” as a barrier.
Adherence to medication was measured by asking
“how often do you take your medicine”; more than
third of them (38.8%) answered “often”. Meanwhile, the
majority of the participants (72.5%) did not have stress
at the time of data collection; those who had experienced
stress responded by repression and keeping silent (41.9%)
or nervousness (53.5%), as represented by screaming,
shouting, or destroying an object) (see Table 4).
3.4. The correlation between BP and selected modifying
factors
A significant correlation was shown between age and BP;
increasing SBP and DBP correlated with increase in age (P
= 0.000) (see Figure 1). Increase in DBP correlated with a
significant increase in cholesterol level (P = 0.002) and BMI
(P = 0.006) (see Figure 2). Meanwhile, an increase in SBP
significantly correlated with an increase in BS (P = 0.007).
The SBP correlated significantly with the BMQ subscales:
patients who believe that a drug is overprescribed (GO) by
their doctor and that a drug is intrinsically harmful (GH),
and who are highly sensitive to its adverse effects (GS)
experience an increase in SBP. However, SBP decreased
among patients who believe in the benefit of the drugs
(GB) prescribed to them (see Table 5).
4. Discussion
This study assessed adherence to lifestyle recommendations
among Jordanian patients having high BP; the current study
highlights the demographics and clinical and behavioral
characteristics of such hypertensive patients. Some
demographics (age, education, marital status, living with
family) and clinical characteristics (systolic and diastolic
BP, co-morbidity, and exercise) of participants are similar
to those in other studies conducted in Jordan (10,22,23).
This means our sample is somewhat representative of
Jordanian patients having high BP. However, in the current
study, around 19% of the participants had high cholesterol
levels and 68.6% were overweight, percentages that were
higher than the findings reported by Al-Nsour et al. (13)
(7.5% and 30.5%, respectively). These differences might
be the result of their participants being diagnosed with
chronic diseases, with their research focusing on more
than hypertension, unlike the current study. Additionally,
around 38% of their participants did not check their
cholesterol levels, whereas all participants in this current
study did so.
Social determinants of health contribute to
hypertension and influence its control when it happens
(4); age was an important independent predictor of

hypertension (23). These findings were congruent with the
current study results in terms of increasing age correlating
significantly with increasing SBP and DBP, high cholesterol
levels being associated with increased DBP, and high
BS being associated with increased SBP. These findings
agreed with the research by Al-Bdour et al., who found a
significant correlation between BS and increased BP (24).
A number of research studies have stated that sodium
intake control helps to reduce BP by 1.4/0.9 mmHg and
accordingly reduce actual and potential complications
(25,26). Our study’s finding showed that adhering to a
prescribed low sodium diet was more successful than
other lifestyle modification options. This result may be
explained by the fact that sodium reduction needs less
time and effort than other processes. Although around
60% of the current study’s participants adhered to a
prescribed sodium reduction program, the means of SBP
and DBP were high (145.7 and 94.7 mmHg, respectively).
This might be rationalized by our participants who did not
adhere to other lifestyle modifications such as measuring
and monitoring their BP, BS, and cholesterol levels, and
who failed to take regular exercise).
Weight loss is correlated with decreased BP (20,27).
A positive relationship was detected between BP and
BMI (23,28,29). More than half of our participants were
overweight and obese and their DBP was correlated with
increased BMI readings. This confirms previous study
findings about adherence to lifestyle modification (11).
These results may be explained by more than half of our
sample not doing any exercise, since they had barriers
preventing them from doing so, such as ‘feeling tired’.
Several studies have shed light on this outcome and have
explained these results (30,31). They claimed that the
simple recommendations of ‘exercise’ or ‘weight control’
were very broad or ambiguous, therefore making them
difficult to be followed by patients (31). On the other
hand, around half of our participants (41%) were doing
exercise but without any effect on their BP; it might
be that the duration of exercise was not sufficient to
play a part in reducing their BP. The data indicate that
intervention to enhance weight reduction and practicing
appropriate exercise (type and duration) should be part
of any comprehensive lifestyle modification intervention.
Moreover, it ensures the focus is on body weight, physical
activity, and salt intake as modifying factors informing
hypertension. This might reduce the high risk factors
relevant to noncommunicable diseases in Jordan (e.g.,
smoking, obesity, and lack of physical activity) (3,13,14).
Meanwhile, this study indicates the importance of proper
management and rational selection of antihypertensive
drug therapy, in order to improve the overall health of the
Jordanian population.
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Table 4. Patients’ health-related behaviors (n = 312) (Jordan, 2013).

Do you have a BP monitor?
Do you measure your BP?

The frequency of
measuring BP

Do you measure your BS?

The frequency of
measuring BS

Smoking

Doing exercise
Type of exercise (for the person
who answers “yes” n = 130)

The extent of difficulties that
you have during exercise

Barriers to exercise
(for the person who
answers “no” n =182)

Sodium reduction diet

Adhere to medication

Having stress
Coping methods (for the person
who answers “yes” to having
stress; n = 86)

Frequency

Percent

Yes

167

53.3

No

145

46.7

Yes

149

47.8

No

163

52.2

Every day

73

23.5

Every week

36

11.5

Every month

6

1.9

Other*

34

10.9

I do not measure it

163

52.2

Yes

111

35.6

No

201

64.4

Every day

44

14.1

Every week

33

10.6

Every month

6

1.9

Other*

28

9

I do not measure it

201

64.4

Currently smoker

70

22.4

I was but I stopped

72

23.1

Never smoke

170

54.5

Yes

130

41.7

No

182

58.3

Walking

113

86.9

Jogging

9

6.9

Others**

8

6.2

No barriers

41

31.5

Minimum

30

23.1

Low

30

23.1

Moderate

29

22.3

High

0

0

Feeling tired

82

45.1

No time

21

11.5

Pain

60

32.9

Shortness of breath

5

2.7

Other***

14

7.8

Yes

186

59.6

No

126

40.4

Always

96

30.8

Often

121

38.8

Sometimes

70

22.4

Once

20

6.4

Never

5

1.6

Yes

86

27.5

No

226

72.5

Repression and being silent

36

41.9

Nervous and angry (screaming, shouting, destroying objects)

46

53.5

Other****

4

4.6

BP: blood pressure
Other*: more than month
Other ***: i.e. drowsiness, long distance to find appropriate place/no appropriate area
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BS: blood sugar
Other**: i.e. boxing, football
Other****: crying, walking around, reading, and eating
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Figure 1. Correlation between systolic BP and age.

Figure 2. Correlation between diastolic BP and BMI.
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Table 5. The Pearson product moment correlation between BP and selected modifying factors.
SBP

P-value

DBP

P-value

Age

0.3**

0.000

0.2**

0.000

Cholesterol level

0.24

0.000

0.2**

0.002

BS

0.11**

0.007

0.045

0.27

BMI

0.033

0.457

0.120**

0.006

General harm

0.159**

0.005

0.082

0.152

General benefit

0.175**

0.002

0.044

0.435

General overuse

0.185**

0.001

0.034

0.556

General sensitivity

0.161**

0.004

0.056

0.322

BMQ subscales

**Correlation is significant at the 0.01 level (2-tailed). SBP: systolic blood pressure
DBP: diastolic blood pressure
BS: blood sugar
BMI: body mass index
BMQ: Beliefs about Medication questionnaire

We tried to minimize the potential bias in this study
by using power calculation and different settings to collect
data. However, the findings of this study are relatively
limited by the use of a descriptive design (weak external
validity), convenience sampling technique, and using a
specially developed self-reported questionnaire (which is
liable to elicit reporting bias). All these reasons limited the
generalizability of the current study.
We conclude from the current study that Jordanian
hypertensive patients did not adhere to lifestyle
modification to any great or meaningful extent. Addressing
behavioral risk factors (physical inactivity, high BS,
increased cholesterol levels, obesity, exposure to stress,
and poor stress management) has a positive impact on
preventing and controlling hypertension. Such prevention
and control strategy consequently reduces the burden
of chronic diseases in terms of morbidity, mortality, and
cost. Therefore, urgent action should be taken by health
policymakers in Jordan to initiate screening programs

for identifying these factors and designing appropriate
interventions to enhance patients’ adherence to healthy
lifestyle modification factors. Health care providers,
particularly nurses, should provide education about these
factors for patient and their family in practice settings. We
recommend that the health policymakers have to cooperate
with the media in order to provide education programs
that aim to reach their target goal, since each house in
Jordan has media technology and so the educational goals
reach the whole population. Future research is needed
to focus on the ways that facilitate patient adherence
to healthy lifestyle recommendations and to assess the
actual barriers that prevent patient from following these
recommendations.
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